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ABSTRACT  
Objective: The aim of the study was to isolate alkaloid compound from seed oil of Derris indica (Lam) Bennett where relevant antimicrobial 
properties in traditional medicines.  
Methods: The plant was selected based on their usage in traditional medicines and ethnopharmacological importance. Crude extract from D. indica 
seeds fractioned with different solvents through column chromatography. Isolated pure fraction was identified and characterized using UV, FTIR, 
1HNMR and Mass spectroscopy.  
Results: D. indica seeds hexane extract on fractionation with ethyl acetate and methanol through column chromatography yielded a crystalline 
fraction. The fraction was identified as alkaloid group and characterized as a 2-(6-methoxyphenanthridin-8-yl) propan-2-ol. The compound is a new 
report from D. indica seed oil. 
Conclusion: The usage of D. indica plant is much in traditional health care for treatment of diseases. Isolation of alkaloid compound from D. indica 
seeds in traditional herbal medicines may be found a good source of drug discovery.  
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INTRODUCTION  
The medicinal plants always played an important role in the global 
health and providing a new area of drug research [1]. Since from 
numerous years, there is increasing a great demand in developing and 
developed countries for plant-based medicines, food supplement, 
health products, pharmaceuticals, and cosmetics. Majority of peoples 
rely on natural products as they are non-toxic, have lesser side effects 
and easily available [2]. Secondary metabolites have been developed 
in nature form of different plant species, insects, fungi, algae, and 
prokaryotes during evolution in enormous diversity. Plant secondary 
metabolites, such as phenolic compounds, flavonoids, alkaloids, and 
tannins are reported to exert numerous biological properties [3, 4]. 
The alkaloids are among the most important active components in 
plants and important classes of secondary metabolites which are 
found to possess important pharmacological properties like analgesic, 
muscle relaxant, antioxidant, anticancer, antibacterial activities, etc. 
Hence, responsible for many therapeutic properties in natural 
medicine and found beneficial for certain life-threatening diseases [3, 
5, 6]. Therefore, there is urgent need to discover new therapeutic 
compounds with diverse chemical structures and with novel 
mechanism of action is required for new and emerging infectious 
diseases [7]. 
Derris indica (Lam) Bennett, a medium-sized evergreen, fast 
growing, glabrous, deciduous nitrogen fixing, bio-diesel tree 
belonging to the family Fabaceae, widely distributed in the region of 
south-east Asia and Pacific Islands [8]. Seeds containing 30-40% oil, 
used for treating various diseases such as piles, skin diseases, 
bronchitis, whooping cough, fever, ulcers etc [8, 9]. D. indica plant 
has various types of chemical compounds [10]. There are several 
reports on presence of wide range of flavonoids in plant with 
antimicrobial activity [11-23]. Numerous compounds have been 
isolated and reported, such as karanjin, pongapin, kanjone, 
pongaglabrone, Pongamosides A, B and C, and a flavonol, glucoside 
and pongamoside D, Pongaglabol and pinnatin [14, 24-26]. 
Biologically active compounds obtained from plant sources have 
always been a great interest for scientists working on infectious and 
non-infectious diseases [27]. Therefore, the aim of the present 
investigation is to isolate alkaloid compound from the D. indica 
seeds. 
MATERIALS AND METHODS  
Plant material 
Mature seeds of D. indica were collected from Gulbarga University 
campus and local areas of Kalaburagi district, Karnataka. The plant 
species initially identified by a field guide and later confirmed by 
herbarium with a voucher specimen (No. HGUG-206) of D. indica 
deposited in the herbarium centre, Department of Botany, Gulbarga 
University, Kalaburagi, Karnataka, India and also with literatures 
[28-30].  
Extraction and isolation of compound 
Seeds were washed with water, shade dried for 8-10 d at room 
temperature and pulverized using a grinder. The seed powder was 
stored in air tight container for further extraction. Dried seed 
powder was subjected to Soxhlet extractor for extraction with 500 
ml of n-hexane for 48h at 40 °C and filtered. Further, extract was 
subjected to thin-layer chromatography (TLC) on silica gel-G plates 
(Hi-media, Mumbai, India) using solvent system ethyl acetate and 
methanol (7:3 v/v) used as mobile phase to separate alkaloid on 
stationary phase. After development, Dragendroff’s reagent test was 
carried out for detection of alkaloid.  
For isolation of compound, obtained extract was dissolved in hexane 
and consecutively, 10g of soluble fractions was subjected to column 
chromatography (Silica gel-H, 60-120Mesh, Hi-media, Mumbai, 
India) using solvents, n-hexane, hexane, petroleum ether, 
chloroform, ethyl acetate, methanol (Sd-fine, Mumbai, India) to 
afford 200 ml fractions each. Subsequently, elution was carried out 
by gradual changing the concentration (90:10, 80:20, 70:30, 60:40, 
50;50, 40:60, 30:70, 20:80 and 10:90 v/v) of above mentioned 
solvents. During elution flow rate was set to 5-10 drops/min. using 
vacuum evaporator each fraction was concentrated and subjected to 
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TLC. Spots was visualized by spraying with 40% H2SO4 (v/v) 
followed by heating at 80 °C for 15 min and TLC plate was detected 
under visible light. Fraction-2, yielded single spot on TLC was 
collected. Purity of compound was confirmed by performing TLC 
studies by using different solvent system as mobile phase. Plates 
were sprayed with Dragendroff’s reagent. Fraction-2 obtained fine 
crystals, further purified by recrystallization from methanol to 
provide pure compound respectively. Obtained compound was 
further identified by UV, FTIR, LCMS and 1HNMR analysis and 
compared with literature data. 
Characterization of isolated compound D2 
Melting point of obtained fraction was determined by Thiele tube 
melting point apparatus. A UV/VIS spectrum was obtained in the 
range of 200-800 nm wavelengths using a 5704SS ELICO 
spectrophotometer. The Fourier transform infrared (FTIR) spectrum 
was measured with a KBr discs in wave numbers (cm-1) in the range 
of 4000-450 cm-1 recorded as inverted peaks using Perkin-Elmer 
RX1 spectrophotometer. Obtained fraction was subjected to mass 
spectrometry analysis (MS) to determine molecular ions present in 
isolated compound. Fraction was analyzed and measured in CDCl3 
(denaturated chloroform, DMSO) with a Shimadzu MS 2010 A 
(temperature of 27 °C) using M-nitrobenzyl alcohol (NBA) as matrix. 
The retention index was determined relative to the retention times 
in JEOl Model GSx 400 spectrometer. NMR was performed to 
determine the structure of the compound, 1HNMR was recorded 
using Bruker AMX 400 NMR spectrometer at 300K in CDCl3 and 
chemical shift was recorded in δ (ppm) and J in hertz value relative 
to Tetramethyl saline (TMS) as internal reference at 400.137 MHz.  
RESULTS AND DISCUSSION 
Identification and characterization of isolated compound D2 
In the present study compound D2, obtained as a pale yellow 
colour crystals (hRf: 86.66) in TLC (ethyl acetate: methanol, 7:3) 
and melting point was recorded as 136-138 °C. UV spectrum 
showed UVλmax nm wavelength at 653.5 and absorbance at 0.262 
(fig. 1). The FTIR spectrum shows the presence of broad main 
absorption band of Hydroxyl group (-OH) at 3358 cm-1 and 
additional moderate intense bands 1059 cm-1, 1275 cm-1 and 1360 
cm-1 present between the ranges (600 cm-1-1600 cm-1). Band 2930 
cm-1 is due to stretching (C-H) and 1652 cm-1shows stretching of 
C=N group (fig. 2). The Mass spectrum indicated the molecular ion 
peak at m/z 267 and base ion peak at m/z 191(fig. 3). Its 
molecular formula was assumed as C17H17NO2 and molecular 
weight is 267.33. The 1H NMR spectrum of compound D2 showed 
signal at δH 8.20 (1H, dd, J= 4Hz), and multiplet between δ 7.77-
7.19 characteristic to aromatic protons, one methoxy protons [δH 
3.95(3H,S)], two methyl and hydroxyl protons exhibited signals 
between [δH 2.0 (1H, br S)-1.27(3H,S)]. The physico-chemical 
properties and spectroscopic data indicated that compound D2 as 
alkaloid and considering the comparative results of spectral studies 
and structure of D2 was predicted as, 2-(6-methoxyphenanthridin-
8-yl) propan-2-ol as shown in fig. 4. These spectroscopic data 
support the proposed structure D2 (fig. 4, table 1). The structure of 
compound was established on the basis of spectroscopic studies. 
 
Table 1: 1H NMR Data for isolated compound D2 (400.137 MHz, 
δ in ppm, J in Hz) 
Position 1a 
3 8.20 (1H, dd, J= 4Hz) 
4 7.46 (1H, d, J= 6.08 Hz) 
5 7.19 (1H, S) 
6 7.46 (1H, d, J= 6.08 Hz) 
9 7.46 (1H, d, J= 6.08 Hz) 
10 7.28 (1H, S) 
13 1.27 (3H, S) 
14 2.0 (1H, br S) 
15 1.2 (3H, S) 
16 7.46 (1H, d, J= 6.08 Hz) 
20 3.95 (3H, S) 
aRecorded in CDCl3 
 
 
Fig. 1: UV spectrum of isolated compound D2 
  
 
Fig. 2: FTIR spectrum of isolated compound D2 
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Fig. 3: Mass spectrum of isolated compound D2 
 
 
Fig. 4: Structure of isolated compound 2-(6-
methoxyphenanthridin-8-yl) propan-2-ol 
 
According to reports, alkaloids are secondary metabolites originally 
defined as pharmacologically active compounds, primarily 
composed of nitrogen [31]. Presence of furanoflavones and isolated 
numerous phytocompounds from D. indica seeds have previously 
reported by many authors [32-35], Pongamol [36-38] and, 
Furanodiketon [39], Karanjachromene[40]isopongachromene [39], 
isoponga flavone [41], O-methyl pongaglabol [38], 3,31,41,7-
tetramethoxyflavone [39], and some fatty acids [42], Pongamoside D 
[15]. The other flavonoid includes Glabrachalcone, 
isopongachromene, Karangin, Glabrachalcone, Isopongachromene 
[43]. A new crystalline compound Pongamol isolated from Pongamia 
oil which crystallizes from alcohol was reported [44]. Pongapin (II) 
has been isolated from the ethanolic extract of seed of P. pinnata. 
The residue crystallized from methanol gives a colourless needle 
[33]. Pongol, a new furanoflavone, obtained as shining yellow 
needles from ethanol [34].  
Several researchers reported that the alkaloids, phenols, 
triterpenoids, glycosides and tannins, have high potential that can be 
developed as antimicrobial compounds against pathogenic 
microorganisms [45, 46]. Natural antimicrobial compounds derived 
from secondary metabolite play a significant role that provide as 
resistance mechanisms against many microorganisms [47-50]. After 
reviewing literatures, this is the first time report of occurrence of 
alkaloid compound from D. indica seed oil and to the best of our 
knowledge; no other studies have been reported. In these 
viewpoints, there is an increasing demand for effective antimicrobial 
agents, justifying in searching new antimicrobial alkaloid drugs. 
CONCLUSION 
In traditional systems of medicines, D. indica has been widely used 
for variety of ailments. The literature survey revealed that D. indica 
is an important medicinal plant and shows the presence of many 
phytoconstituents responsible for varied medicinal properties. 
Alkaloid compound D2 with desirable phytochemical, certainly 
encourages future advanced research and provides a significant 
basis for the development of pharmaceutical drug.  
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